Skip to content
healthcare.dev
Get a free key

Diatrizoate Meglumine and Diatrizoate Sodium

NDC 53041-690, Diatrizoate Meglumine and Diatrizoate Sodium, solution, from Guardian Drug Company.

Product NDC
53041-690
Status
Listed
Labeler
Guardian Drug Company
Dosage form
SOLUTION
Route
ORAL, RECTAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA214201
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53041-690 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DIATRIZOATE MEGLUMINE660 mg/mL
  • DIATRIZOATE SODIUM100 mg/mL

Pharmacologic classes

Radiographic Contrast Agent [EPC]; Radiographic Contrast Agent [EPC]; X-Ray Contrast Activity [MoA]; X-Ray Contrast Activity [MoA]

Package NDCNDC-11Package
53041-690-0353041069003120 mL in 1 BOTTLE, GLASS (53041-690-03)
53041-690-095304106900930 mL in 1 BOTTLE, GLASS (53041-690-09)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e9da4d3d-d0ca-44f7-aaeb-ae49c3839775

Use it

Look up 53041-690 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53041-690 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53041-690. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.